In principle, the first author must be a member of the Japanese Society for Transplantation and
Cellular Therapy (JSTCT) at the time of abstract submission. However, this excludes residents
and
undergraduate students (who must submit a separate certificate), and those who belong to
institutions or organizations outside Japan.
To submit an abstract, the following criteria must be met:
The content of the submitted abstract must fit into one of the JSTCT2026 Abstract Review
Categories.
Abstracts with the same content as a paper already submitted to a journal will be accepted for
submission if it has not yet been published.
Abstracts presented at other conferences (including in another language) will be accepted if it
contains important and new information or the conclusion has been changed after adding new data.
Any of the following criteria will make an abstract ineligible for presentation:
The same content already been published in an academic journal at the time of abstract
submission.
The same content already been presented in other academic meetings at the time of abstract
submission.
Main Category | Sub Category |
---|---|
01. Stem Cell Biology | |
02. Histocompatibility Antigen | |
03. Stem Cell Mobilization and Harvest | |
04. Stem Cell Source | |
05. Conditioning Regimens | |
06. Supportive Care | |
07. Transplant Immunity | 07-1. Immune Reconstitution |
07-2. Acute GVHD | |
07-3. Chronic GVHD | |
07-4. GVL | |
07-5. Others | |
08. Immunotherapy / Cell therapy / Gene therapy | 08-1. Preclinical |
08-2. Clinical | |
09. Child-specific Transplant Disease (Inborn errors of metabolism, Congenital immune deficiency and others) | |
10. Transplant Outcomes | 10-1. Acute Leukemia |
10-2. Myelodysplastic Syndrome / Myeloproliferative Tumor | |
10-3. Malignant Lymphoma/ATL | |
10-4. Multiple Myeloma / Plasma Cell Disorders | |
10-5. Aplastic Anemia | |
10-6. Others | |
11. Minimal Residual Disease and Relapse | |
12. Early Complications | 12-1. Engraftment Failure |
12-2. TMA | |
12-3. VOD / SOS | |
12-4. Others | |
13. Late Complications | |
14. Infection | 14-1. Bacterial Infection |
14-2. Fungal Infection | |
14-3. Viral Infection | |
14-4. Others | |
15. Follow-up and QOL | |
16. Marrow Donor Program / Cord Blood Bank / Donors | |
17. Hematopoietic Cell Transplant Coordinator and Coordinate | |
18. Care | 18-1. Oral Care |
18-2. Skin Care | |
18-3. GVHD Care | |
18-4. Mental Care | |
18-5. Others | |
19. Management | 19-1. Infection Control |
19-2. Meal Management | |
19-3. Nutrition Management | |
19-4. Others | |
20. Rehabilitation | |
21. Nursing / Education | |
22. TDM / Drugs | |
23. Team Medical-care | |
24. AI-based analysis |
pagetop